Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications

Journal of Hepatology

Volumn 14, Issue 1, 1992, Pages 104-111

  O'Grady, John G ^a   Smith, Heather M ^a   Davies, Susan E ^a   Daniels, Helena M ^a   Donaldson, Peter T ^a   Tan, K C ^a   Portmann, Bernard ^a   Alexander, Graeme J M ^a   Williams, Roger ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; SEROLOGY; VIRUS INFECTION;

ADULT; DNA, VIRAL; FEMALE; GRAFT REJECTION; HEPATITIS B; HEPATITIS B E ANTIGENS; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMAN; LIVER TRANSPLANTATION; MALE; MIDDLE AGE; TIME FACTORS; TRANSAMINASES;

EID: 0026501529     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8278(92)90138-F     Document Type: Article

References (27)

1. Experience in 1000 liver transplants under cyclosporine-steroid therapy: a survival report
2. Medical aspects of liver transplantation
3. Results of liver transplantation for hepatitis delta virus disease without immunoprophylaxis
4. Graft hepatitis delta virus reinfection after orthotopic liver transplantation in HDV cirrhosis
5. Medical problems before and after transplantation
6. Recurrent hepatitis B in liver allografts recipients: differentiation between viral Hepatitis B and rejection
7. Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts
8. Liver transplantation in hepatitis delta virus disease
9. Delta infection and liver disease recurrence in hepatic allografts
10. Long-term results after liver transplantation in B and delta hepatitis
11. Pre-treatment assessment laparotomy in tumour cases, recipient operation in adults and in children and retransplantation
12. Orthotopic liver transplantation: improved surgical techniques and early postoperative complications
13. An analysis of cyclosporine efficacy and toxicity after liver transplantation
14. Quantitation of hepatitis B virus DNA (HBV-DNA) in serum using the spot hybridization technique and scintillation counting
15. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis
16. Detection of hepatitis B virus DNA in mononuclear blood cells
17. Detection of hepatitis B virus DNA in spermatozoa, urine, saliva and leucocytes, of chronic HBsAg carriers: a lack of relationship with serum markers of replication
18. Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection
19. Evolution of hepatitis B virus in liver disease after hepatic replacement
20. Multiplication of hepatitis B virus in fulminant hepatitis B
21. Delta-infection and suppression of hepatitis B virus replication in chronic HBsAg carriers
22. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients: a prospective study of 90 patients
23. Cholestatic jaundice after hepatic transplantation: a nonimmunologically mediated event
24. Renal transplantation and hepatitis B
25. Chronic hepatitis in end-stage renal disease: comparison of HBsAg-negative and HBsAg-positive patients
26. HLA class I matching is responsible for the hepatic lesions in recurrent viral hepatitis after liver transplantation
27. Long-term results after liver transplantation in B and delta hepatitis